Founded in February 2014, 4D pharma plc is a world leader in the development of Live Biotherapeutic products (“LBPs”), a disruptive class of drug, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx®, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.
Clinical benefit data announced today
4D Pharma Plc
You’re best to add your vote to this one my friend…
We’ll add this next week as part of the Plus membership universe as it’s a constituent of the FTSE AIM All-Share.
Think you added n4 pharma this is 4D pharma - perhaps next week ?
Yes, it’s on the list for the next mega batch.
Market likes the NASDAQ listing news!
via a SPAC for those interested in SPACs
The ticker symbol is very special and easy to remember.